EnableInsights
Get in touch

Contracts Finder · Planning

Specialised - Recombinant Factor IX

A public procurement published by NHS ENGLAND via Contracts Finder.

Contracts FinderPlanning
—
Award value
£96m
Tender value
0
Suppliers
0
Awards
7
Notices
Planning
Stage

Overview

Recombinant Factor IX

Key details

Buyer
NHS ENGLAND
Source
Contracts Finder
Lifecycle stage
Planning
Status
planned
CPV classification
33141530 — Blood coagulants
Currency
GBP
Total award value
—
Tender value
£96,000,000
First published
23 May 2017
Last updated
18 Oct 2018
View the original notice

Notice timeline

Every published notice in this procurement's lifecycle.

  1. Planning noticeSpecialised - Recombinant Factor IX
  2. Planning noticeSpecialised - Recombinant Factor IX
  3. Planning noticeSpecialised - Recombinant Factor IX
  4. Planning noticeSpecialised - Recombinant Factor IX
  5. Planning noticeSpecialised - Recombinant Factor IX
  6. Planning noticeSpecialised - Recombinant Factor IX
  7. Planning noticeSpecialised - Recombinant Factor IX

Frameworks & programmes

More from NHS ENGLAND

Products for the treatment of Haemophilia A
Planning · Contracts Finder
NHS Framework Agreement for the supply of Adult Influenza Vaccines - Secondary Care
Planning · Contracts Finder
NHS Framework Agreement for the supply of products for the teratment of Haemophilia A
Planning · Contracts Finder
NHS National Framework Agreement for the supply of Haemophilia A
Planning · Contracts Finder
Adult Influenza Vaccines - Secondary Care
Planning · Contracts Finder
NHS Framework Agreement for the Supply of Human Normal Immunoglobulin & Anti-D Immunoglobulin
Planning · Contracts Finder

FAQs about this procurement

Who is the buyer for "Specialised - Recombinant Factor IX"?

Specialised - Recombinant Factor IX is a UK public-sector procurement published by NHS ENGLAND via Contracts Finder.

Has "Specialised - Recombinant Factor IX" been awarded?

No award has been recorded yet. The current lifecycle stage is "Planning".

What is "Specialised - Recombinant Factor IX" worth?

The reported tender value is £96,000,000.

When was "Specialised - Recombinant Factor IX" published?

It was first published on 23 May 2017 and last updated on 18 Oct 2018, across 7 notices.

Track procurements like this one

Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.

Get in touch with Enable